APP announced that it will launch Imipenem and Cilastatin for Injection and Meropenem for Injection, generic versions of Primaxin IV (Merck) and Merrem IV (AstraZeneca), respectively. It is ...
LAKE FOREST, Ill., June 22 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced it has ...
June 2, 2005 — The U.S. Food and Drug Administration (FDA) has approved extended-release dexmethylphenidate HCl capsules for once-daily treatment of attention deficit/hyperactivity disorder in adults, ...
The Drugs Controller General (India) (DCGI) has informed all state drug regulators that the Central regulatory authority has not approved manufacturing and marketing of antibiotic combination of ...
The Drugs Controller General (India) (DCGI) has directed the state drug regulators in the country to cancel the product permission granted by them for manufacturing and marketing of certain antibiotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback